PETER 

 

BISGAARD 

DIRECTOR

M2 GROUP HOLDINGS INC   |  LIGHT SCIENCES ONCOLOGY INC   |  OTONOMY, INC.   |  HIGH THROUGHPUT GENOMICS INC   |  HTG MOLECULAR DIAGNOSTICS INC   |  ALTHEOS, INC.   |  THESAN PHARMACEUTICALS, INC.   |  CETERIX ORTHOPAEDICS, INC.   |  HTG MOLECULAR DIAGNOSTICS, INC   |  RA PHARMACEUTICALS, INC.   |  OUTPOST MEDICINE, LLC   |  BOLT BIOTHERAPEUTICS, INC.   |  EARGO, INC.   |  ONCXERNA THERAPEUTICS, LTD.   |  MAPLIGHT THERAPEUTICS, INC.   |  ADDITION THERAPEUTICS, INC.

KATHLEEN 

 

COLLINS 

DIRECTOR

KARNATEQ, INC.   |  ADDITION THERAPEUTICS, INC.

LAWRENCE 

 

KONG 

EXECUTIVE OFFICER

ADDITION THERAPEUTICS, INC.

JENNIFER 

 

LEE 

DIRECTOR

DERMBIONT, INC.   |  T.Y.LIN INTERNATIONAL GROUP, LTD.   |  LEEGEN INVESTMENT LLC   |  K1X CO-INVEST, LLC   |  ADDITION THERAPEUTICS, INC.

RONALD 

 

PARK 

EXECUTIVE OFFICER, DIRECTOR

ADDITION THERAPEUTICS, INC.

MATTHEW 

 

PATTERSON 

DIRECTOR

AUDENTES THERAPEUTICS, INC.   |  CONFLUENCECX SPE29 LLC   |  CONFLUENCECX SPV ESCAMPA A SERIES OF ATOMIZER LLC   |  REMIX THERAPEUTICS, INC.   |  ADDITION THERAPEUTICS, INC.

JAYSON 

 

PUNWANI 

DIRECTOR

ARMAGEN, INC.   |  VELOSBIO INC.   |  ADDITION THERAPEUTICS, INC.

LAETITIA 

 

SCHWAB 

DIRECTOR

ADDITION THERAPEUTICS, INC.